Prestige Consumer Healthcare Inc. (PBH)
| Market Cap | 2.25B-24.3% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 47.37M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 460,851 |
| Open | 46.57 |
| Previous Close | 46.44 |
| Day's Range | 46.34 - 47.72 |
| 52-Week Range | 42.62 - 71.07 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 81.67(+71.68%) |
| Earnings Date | n/a |
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PBH stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in PBH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PBH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PBH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PBH Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Gastrointestinal | $62.20M | 23.41% |
| Women's Health | $52.54M | 19.77% |
| Dermatologicals | $33.20M | 12.49% |
| Eye & Ear Care | $32.98M | 12.41% |
| Pain Relief | $26.80M | 10.09% |
| Oral Care | $22.36M | 8.41% |
| Cough, Cold & Allergy | $21.30M | 8.02% |
| Wellness, Sleep & Other | $14.33M | 5.39% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PBH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PBH from public contracts
Source: USAspending.gov
PBH Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PBH’s recent data — informational, not investment advice
